Clinical Trials Directory

Trials / Completed

CompletedNCT01256320

Egg Study With Peripheral Arterial Disease

The Impact of Egg Consumption on Indices of Vascular Health in Individuals With Peripheral Arterial Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Manitoba · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The current research study has the potential to generate data that would provide solid clinical endpoints as to the impact of including eggs in a regular diet in individuals with peripheral arterial disease. Any one of three potential outcomes may be observed as a result of this study, and they are predicted as follows: 1) Egg consumption does not lead to a deterioration of indices of cardiovascular health; 2) Egg consumption improves indices of cardiovascular health; 3) Egg consumption worsens the indices of cardiovascular health.

Detailed description

Given the hypotheses proposed, if either of the first two predictions prove to be positive, they will help encourage directive efforts to be made toward effective nutrition messages for egg consumption in the peripheral arterial disease and the healthy population. If the last prediction is positive, while least favourable, it will still establish important information to assist the industry in their efforts toward establishing population-specific nutrition messaging.

Conditions

Interventions

TypeNameDescription
OTHERClassic Egg Groupconsumption of 6 eggs/week (1 egg/day for 6 days with 1 day rest) of commercial classic eggs
OTHEROmega 3 Egg Groupconsumption of 6 eggs/week (1 egg/day for 6 days with 1 day rest) of commercial Omega-3 eggs

Timeline

Start date
2010-06-01
Primary completion
2012-12-01
Completion
2013-02-01
First posted
2010-12-08
Last updated
2017-05-04

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01256320. Inclusion in this directory is not an endorsement.